These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28782621)
21. Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells. Lin J; Zhou J; Zhong X; Hong Z; Peng J Mol Med Rep; 2015 Mar; 11(3):2207-14. PubMed ID: 25394909 [TBL] [Abstract][Full Text] [Related]
22. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase. Choi HM; Jung Y; Park J; Kim HL; Youn DH; Kang J; Jeong MY; Lee JH; Yang WM; Lee SG; Ahn KS; Um JY Sci Rep; 2016 Aug; 6():31906. PubMed ID: 27549514 [TBL] [Abstract][Full Text] [Related]
23. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells. Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062 [TBL] [Abstract][Full Text] [Related]
24. Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation. Iglesias-Gato D; Carsten T; Vesterlund M; Pousette A; Schoop R; Norstedt G Phytother Res; 2012 Feb; 26(2):259-64. PubMed ID: 21656602 [TBL] [Abstract][Full Text] [Related]
25. Flavonoids derived from Anemarrhenae Rhizoma ameliorate inflammation of benign prostatic hyperplasia via modulating COX/LOX pathways. Cao X; Shang Y; Kong W; Jiang S; Liao J; Dai R J Ethnopharmacol; 2022 Feb; 284():114740. PubMed ID: 34737006 [TBL] [Abstract][Full Text] [Related]
26. Proliferation of prostate epithelia induced by IL-6 from stroma reacted with Trichomonas vaginalis. Kim JH; Han IH; Kim YS; Noh CS; Ryu JS Parasite Immunol; 2018 Jun; 40(6):e12531. PubMed ID: 29633291 [TBL] [Abstract][Full Text] [Related]
27. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis. Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529 [TBL] [Abstract][Full Text] [Related]
28. Combining untargeted and targeted metabolomics to reveal the mechanisms of herb pair Anemarrhena asphodeloides Bunge and Phellodendron chinense C. K. Schneid on benign prostatic hyperplasia. Wang S; Ju C; Chen M; Zhai Q; Cheng C; Zhou W; Xue L; Xu C; Tan X; Dai R J Ethnopharmacol; 2024 Nov; 334():118539. PubMed ID: 38986754 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis. Kim SS; Kim JH; Han IH; Ahn MH; Ryu JS Korean J Parasitol; 2016 Apr; 54(2):123-32. PubMed ID: 27180569 [TBL] [Abstract][Full Text] [Related]
30. Epigallocatechin-3-gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions. Tepedelen BE; Soya E; Korkmaz M Life Sci; 2017 Dec; 191():74-81. PubMed ID: 29032114 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells. Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654 [TBL] [Abstract][Full Text] [Related]
32. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia. Said MM; Hassan NS; Schlicht MJ; Bosland MC J Toxicol Environ Health A; 2015; 78(7):453-65. PubMed ID: 25785559 [TBL] [Abstract][Full Text] [Related]
34. Sutapa H; Widodo MA; Purnomo BB; Soebadi DM; Negara EP Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):68-74. PubMed ID: 32129166 [TBL] [Abstract][Full Text] [Related]
35. Effects of Saussurea costus on apoptosis imbalance and inflammation in benign prostatic hyperplasia. Choi DH; Kim JY; An JH; Sung SH; Kong HS J Ethnopharmacol; 2021 Oct; 279():114349. PubMed ID: 34171398 [TBL] [Abstract][Full Text] [Related]
36. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway. Xu H; Fu S; Chen Y; Chen Q; Gu M; Liu C; Qiao Z; Zhou J; Wang Z Clin Sci (Lond); 2017 Apr; 131(7):595-607. PubMed ID: 28130436 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Castro P; Xia C; Gomez L; Lamb DJ; Ittmann M Prostate; 2004 Jul; 60(2):153-9. PubMed ID: 15162381 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia. Rick FG; Schally AV; Block NL; Abi-Chaker A; Krishan A; Szalontay L Prostate; 2013 Jun; 73(8):873-83. PubMed ID: 23280565 [TBL] [Abstract][Full Text] [Related]
39. Anti-Proliferation Effects of Garlic (Allium sativum L.) on the Progression of Benign Prostatic Hyperplasia. Chung KS; Shin SJ; Lee NY; Cheon SY; Park W; Sun SH; An HJ Phytother Res; 2016 Jul; 30(7):1197-203. PubMed ID: 27191676 [TBL] [Abstract][Full Text] [Related]
40. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]